Vertex Pharmaceuticals (VRTX) Share-based Compensation (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Share-based Compensation of $108.1 million for Q2 2026, down 52.69% on a QoQ basis from $228.5 million in Q1 2026, and up 71.86% year-over-year from $62.9 million in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Share-based Compensation (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Share-based Compensation for 18 years, with the latest figure at $108.1 million in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 71.86% year-over-year to $108.1 million in Q2 2026; TTM through Jun 2026 was $689.1 million, a 0.48% change from a year earlier, with the FY2025 full-year figure at $685.9 million, down 1.8% from the prior year.
- Share-based Compensation was $108.1 million for Q2 2026 at Vertex Pharmaceuticals, down from $228.5 million in the prior quarter.
- The five-year high for Share-based Compensation was $270.5 million in Q1 2025, with the low at $62.9 million in Q2 2025.
- Average Share-based Compensation over 5 years is $155.2 million, with a median of $146.6 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Share-based Compensation soared 87.09% in 2023, then sank 44.14% in 2025.
- Over 5 years, Share-based Compensation stood at $111.5 million in 2022, then soared by 87.09% to $208.6 million in 2023, then slipped by 19.56% to $167.8 million in 2024, then declined by 6.08% to $157.6 million in 2025, then tumbled by 31.41% to $108.1 million in 2026.
- The last three Share-based Compensation figures came in at $108.1 million (Q2 2026), $228.5 million (Q1 2026), and $157.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | -950.00 Mn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 247.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 108.10 Mn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 135.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.10 Mn |
| Mar 31, 2026 | 228.50 Mn |
| Dec 31, 2025 | 157.60 Mn |
| Sep 30, 2025 | 194.90 Mn |
| Jun 30, 2025 | 62.90 Mn |
| Mar 31, 2025 | 270.50 Mn |
| Dec 31, 2024 | 167.80 Mn |
| Sep 30, 2024 | 184.60 Mn |
| Jun 30, 2024 | 112.60 Mn |
| Mar 31, 2024 | 233.50 Mn |
| Dec 31, 2023 | 208.60 Mn |
| Sep 30, 2023 | 130.90 Mn |
| Jun 30, 2023 | 75.10 Mn |
| Mar 31, 2023 | 166.60 Mn |
| Dec 31, 2022 | 111.50 Mn |
| Sep 30, 2022 | 135.60 Mn |
| Jun 30, 2022 | 113.90 Mn |
| Mar 31, 2022 | 130.30 Mn |
| Dec 31, 2021 | 118.60 Mn |
| Sep 30, 2021 | 103.00 Mn |
API Access
Vertex Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();